Cibus Global Ltd. Class A
Research Cibus Global Ltd. Class A (CBUS) on Bullrun: market cap USD 118.46M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCBUS
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 118.46M
- Financial periodQ2 2026
- RevenueUSD 994.00K
- Net income-USD 22.15M
- Free cash flow-USD 9.37M
Valuation Snapshot
latest market cap is USD 118.46M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 3.64M | -USD 127.09M | -USD 51.17M | 100.0% | -2.78 | USD 9.92M | USD 528.00K | USD 21.83M |
| FY2024 | USD 4.26M | -USD 251.39M | -USD 58.85M | 100.0% | -10.83 | USD 14.43M | USD 662.00K | USD 92.16M |
| FY2023 | USD 1.82M | -USD 267.63M | -USD 50.53M | 100.0% | -25.95 | USD 32.70M | USD 1.37M | USD 293.47M |
| FY2022 | USD 157.00K | -USD 16.89M | -USD 20.88M | 100.0% | -18.36 | USD 3.43M | USD 0 | USD 7.23M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 118.46M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 94.53M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 77.67M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 330.73M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 7.23M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 82.59M | n/a | n/a | n/a |
About Cibus Global Ltd. Class A
Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Cibus Global Ltd. Class A's market cap?
Cibus Global Ltd. Class A's market capitalization is USD 118.46M.
What does Cibus Global Ltd. Class A do?
Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc.